Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes
Clinical trial NCT03235973 · UNKNOWN
Trial details
- NCT number
- NCT03235973
- Sponsor
- Institut Paoli-Calmettes
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-28
- Primary completion
- 2020-04-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.